![Eugene Helsel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eugene Helsel formerly worked at Capricor, Inc., as Senior Director-Regulatory Affairs, Fate Therapeutics, Inc., as Executive Director-Regulatory Affairs & Quality, and Artiva Biotherapeutics, Inc., as Vice President-Regulatory Affairs & Quality.
Mr. Helsel received his undergraduate degree from National University and undergraduate degree from the University of California San Diego.
| Companies | Position | End |
|---|---|---|
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Corporate Officer/Principal | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| ARTIVA BIOTHERAPEUTICS, INC. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Provides cardiac stem cell therapeutics biotechnology services | Health Technology |
National University
 National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
